Cellular FLICE-like inhibitory protein (c-FLIP): A novel target for Taxol-induced apoptosis

Biochemical Pharmacology

Volumn 71, Issue 11, 2006, Pages 1551-1561

  Day, Travis W ^a   Najafi, Farhad ^a   Wu, Ching Huang ^a   Safa, Ahmad R ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Apoptosis; C FLIP; Caspase 10; Caspase 8; Death receptors; Taxol

Indexed keywords

CASPASE 10; CASPASE 8; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; ISOPROTEIN; PACLITAXEL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHATIC LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 10; CASPASE 8; CASPASES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, T-CELL, ACUTE; PACLITAXEL;

EID: 33646086961     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.02.015     Document Type: Article

References (39)

1. Fields A.L., and Runowicz C.D. Current therapies in ovarian cancer. Cancer Invest 21 1 (2003) 148-156
2. Crown J., O'Leary M., and Ooi W.S. Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience. Oncologist 9 Suppl 2 (2004) 24-32
3. Simon G.R., and Bunn Jr. P.A. Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments. Cancer Invest 21 1 (2003) 87-104
4. Jordan M.A., and Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 4 4 (2004) 253-265
5. Jordan M.A., Toso R.J., Thrower D., and Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90 20 (1993) 9552-9556
6. Jordan M.A., Wendell K., Gardiner S., Derry W.B., Copp H., and Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56 4 (1996) 816-825
7. Torres K., and Horwitz S.B. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 58 16 (1998) 3620-3626
8. Wang T.H., Wang H.S., and Soong Y.K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88 11 (2000) 2619-2628
9. Giannakakou P., Robey R., Fojo T., and Blagosklonny M.V. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20 29 (2001) 3806-3813
10. Pushkarev V.M., Starenki D.V., Saenko V.A., Namba H., Kurebayashi J., Tronko M.D., et al. Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells. Endocrinology 145 7 (2004) 3143-3152 [Epub, March 24, 2004]
11. Brichese L., and Valette A. PP1 phosphatase is involved in Bcl-2 dephosphorylation after prolonged mitotic arrest induced by paclitaxel. Biochem Biophys Res Commun 294 2 (2002) 504-508
12. Stone A.A., and Chambers T.C. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Exp Cell Res 254 1 (2000) 110-119
13. Lee L.F., Li G., Templeton D.J., Ting J.P., and Paclitaxel. (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J Biol Chem 273 43 (1998) 28253-28260
14. Park S.J., Wu C.H., Gordon J.D., Zhong X., Emami A., and Safa A.R. Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279 49 (2004) 51057-51067 [Epub]
15. Abe K., Kurakin A., Mohseni-Maybodi M., Kay B., and Khosravi-Far R. The complexity of TNF-related apoptosis-inducing ligand. Ann NY Acad Sci 926 (2000) 52-63
16. Krueger A., Schmitz I., Baumann S., Krammer P.H., and Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276 23 (2001) 20633-20640 [Epub, March 5, 2001]
17. Ozoren N., and El-Deiry W.S. Cell surface death receptor signaling in normal and cancer cells. Semin Cancer Biol 13 2 (2003) 135-147
18. Debatin K.M., and Krammer P.H. Death receptors in chemotherapy and cancer. Oncogene 23 (2004) 16
19. Thorburn A. Death receptor-induced cell killing. Cell Signal 16 2 (2004) 139-144
20. Golks A., Brenner D., Fritsch C., Krammer P.H., and Lavrik I.N. c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 280 15 (2005) 14507-14513
21. Sharp D.A., Lawrence D.A., and Ashkenazi A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem 280 19 (2005) 19401-19409 [Epub, March 10, 2005]
22. Krueger A., Baumann S., Krammer P.H., and Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol 21 24 (2001) 8247-8254
23. Kataoka T., and Tschopp J. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol Cell Biol 24 7 (2004) 2627-2636
24. Micheau O., and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 2 (2003) 181-190
25. Kim Y., Suh N., Sporn M., and Reed J.C. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J Biol Chem 277 25 (2002) 22320-22329 [Epub, April 8, 2002]
26. Poukkula M., Kaunisto A., Hietakangas V., Denessiouk K., Katajamaki T., Johnson M.S., et al. Rapid turnover of c-FLIPS is determined by its unique C-terminal tail. J Biol Chem 10 (2005) 10
27. Dutton A., O'Neil J.D., Milner A.E., Reynolds G.M., Starczynski J., Crocker J., et al. Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death. Proc Natl Acad Sci USA 101 17 (2004) 6611-6616 [Epub, April 19, 2004]
28. Jin T.G., Kurakin A., Benhaga N., Abe K., Mohseni M., Sandra F., et al. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5. J Biol Chem 279 53 (2004) 55594-55601 [Epub, October 14, 2004]
29. Wajant H. Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy. Mol Interv 3 3 (2003) 124-127
30. Garvey T.L., Bertin J., Siegel R.M., Wang G.H., Lenardo M.J., and Cohen J.I. Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J Virol 76 2 (2002) 697-706
31. Benoit V., Chariot A., Delacroix L., Deregowski V., Jacobs N., Merville M.P., et al. Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expression. Cancer Res 64 8 (2004) 2684-2691
32. Yeh W.C., Itie A., Elia A.J., Ng M., Shu H.B., Wakeham A., et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12 6 (2000) 633-642
33. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., et al. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. Embo J 21 14 (2002) 3704-3714
34. Burns T.F., and El-Deiry W.S. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J Biol Chem 276 41 (2001) 37879-37886 [Epub, August 2, 2001]
35. Bin L., Li X., Xu L.G., and Shu H.B. The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis. FEBS Lett 510 1/2 (2002) 37-40
36. Peter M.E. The flip side of FLIP. Biochem J 382 Pt 2 (2004) e1-e3
37. Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D.W., et al. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 277 47 (2002) 45162-45171 [Epub, September 4, 2002]
38. Boatright K.M., Deis C., Denault J.B., Sutherlin D.P., and Salvesen G.S. Activation of caspases-8 and -10 by FLIP(L). Biochem J 382 Pt 2 (2004) 651-657
39. Longley D.B., Wilson T.R., McEwan M., Allen W.L., McDermott U., Galligan L., et al. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death. Oncogene 17 (2005) 17